A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Status:
Terminated

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

The purpose of this study is to determine if CP-945,598 is effective in the treatment of obesity in type 2 diabetic patients.

Phase 3

Pfizer